3’-O-Levulinyl-2’-deoxyadenosine
3’-O-Levulinyl-2’-deoxyadenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
440327-45-7
UNSPSC
12352005
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/3-o-levulinyl-2-deoxyadenosine.html
Solubility
10 mM in DMSO
Smiles
OC[C@@H]1[C@@H](OC(CCC(C)=O)=O)C[C@H](N2C(N=CN=C3N)=C3N=C2)O1
Molecular Formula
C15H19N5O5
Molecular Weight
349.34
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
InstantChek Carbohydrate Identification Kit #2 One Minute Kit for Differentiating Branched or linear Mannose
Eph receptor A4 (EPHA4) Human Gene Knockout Kit (CRISPR)
Desmin (Muscle Cell Marker) (DES/1711), Biotin conjugate, 0.1mg/mL
CD45 / LCA (Leucocyte Marker) (PTPRC/1147 + PTPRC/1460), CF488A conjugate, 0.1mg/mL
